Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection.
Van Elslande J, Oyaert M, Lorent N, Vande Weygaerde Y, Van Pottelbergh G, Godderis L, Van Ranst M, André E, Padalko E, Lagrou K, Vandendriessche S, Vermeersch P.
Van Elslande J, et al. Among authors: van pottelbergh g, van ranst m.
Diagn Microbiol Infect Dis. 2022 May;103(1):115659. doi: 10.1016/j.diagmicrobio.2022.115659. Epub 2022 Feb 12.
Diagn Microbiol Infect Dis. 2022.
PMID: 35278794
Free PMC article.